Enavate Sciences GP, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001953107 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $133M (100.0% shares, 0.0% debt)

Holdings (6)

IMNM IMMUNOME INC 24.2%

Value $32.09M Shares 4,768,583 Est. Cost $11.41 Unrealized -15.9%

ZBIO ZENAS BIOPHARMA INC 22.4%

Value $29.71M Shares 3,761,359 Est. Cost $15.60 Unrealized -49.8%

SION SIONNA THERAPEUTICS INC 19.5%

Value $25.92M Shares 2,478,030 Est. Cost $16.34 Unrealized 0.0%

CAMP CAMP4 THERAPEUTICS CORP 11.4%

Value $15.14M Shares 3,785,802 Est. Cost $8.22 Unrealized -41.1%

UPB UPSTREAM BIO INC 11.3%

Value $15.05M Shares 2,459,703 Est. Cost $22.33 Unrealized -57.2%

CMPX COMPASS THERAPEUTICS INC 11.1%

Value $14.8M Shares 7,788,150 Est. Cost $1.66 Unrealized +60.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
IMNM	IMMUNOME INC	4,768,583	$32.09M	24.2%	$11.41	-15.9%	COM	45257U108
ZBIO	ZENAS BIOPHARMA INC	3,761,359	$29.71M	22.4%	$15.60	-49.8%	COM	98937L105
SION	SIONNA THERAPEUTICS INC	2,478,030	$25.92M	19.5%	$16.34	0.0%	COM	829401108
CAMP	CAMP4 THERAPEUTICS CORP	3,785,802	$15.14M	11.4%	$8.22	-41.1%	COM	13463J101
UPB	UPSTREAM BIO INC	2,459,703	$15.05M	11.3%	$22.33	-57.2%	COM	91678A107
CMPX	COMPASS THERAPEUTICS INC	7,788,150	$14.8M	11.1%	$1.66	+60.1%	COM	20454B104